Activity profiles of antimutagens: in vitro and in vivo data.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 8657173)

Published in Mutat Res on February 19, 1996

Authors

M D Waters1, H F Stack, M A Jackson, H E Brockman, S De Flora

Author Affiliations

1: U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA.

Articles by these authors

Early onset Haemophilus influenzae sepsis in the newborn infant. Pediatr Infect Dis J (1993) 2.20

Detection of animal viruses in coastal seawater and sediments. Appl Microbiol (1975) 2.01

Relatively penicillin-resistant pneumococcal infections in pediatric patients. Pediatr Infect Dis (1984) 1.98

Toxicity and mutagenicity of hexavalent chromium on Salmonella typhimurium. Appl Environ Microbiol (1977) 1.84

Clinical utility of polymerase chain reaction testing for enteroviral meningitis. Pediatr Infect Dis J (1999) 1.62

Antigenic characterization of the oligosaccharide portion of the lipooligosaccharide of nontypable Haemophilus influenzae. Infect Immun (1987) 1.59

Etiology and medical management of acute suppurative bone and joint infections in pediatric patients. J Pediatr Orthop (1982) 1.54

Transient neonatal hypothyroidism due to a maternal vegan diet. J Pediatr Endocrinol Metab (2003) 1.50

Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns. Carcinogenesis (2007) 1.48

Use of computerized data listings and activity profiles of genetic and related effects in the review of 195 compounds. Mutat Res (1988) 1.46

Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside. Pediatr Infect Dis J (1989) 1.45

Self-Assembled Metal Colloid Monolayers: An Approach to SERS Substrates. Science (1995) 1.45

Delayed renal revascularisation after enalapril induced renal failure in renal artery stenosis. Eur J Vasc Endovasc Surg (1996) 1.38

Near-fatal hyponatraemic coma due to vasopressin over-secretion after "ecstasy" (3,4-MDMA) Lancet (1996) 1.29

A survey of EPA/OPP and open literature data on selected pesticide chemicals tested for mutagenicity. I. Introduction and first ten chemicals. Mutat Res (1993) 1.20

Germination of conidia and blastospores of Paecilomyces fumosoroseus on the cuticle of the silverleaf whitefly, Bemisia argentifolii. Mycopathologia (1999) 1.19

Two circadian rhythms in the human electroencephalogram during wakefulness. Am J Physiol (1999) 1.19

Evidence from the waking electroencephalogram that short sleepers live under higher homeostatic sleep pressure than long sleepers. Neuroscience (2001) 1.14

Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine. Cancer Res (2001) 1.13

Antimutagenicity profiles for some model compounds. Mutat Res (1990) 1.11

The role of the thiol N-acetylcysteine in the prevention of tumor invasion and angiogenesis. Int J Biol Markers (2000) 1.11

Induction by carcinogens and chemoprevention by N-acetylcysteine of adducts to mitochondrial DNA in rat organs. Cancer Res (1996) 1.11

N-acetyl-l-cysteine. J Cell Biochem Suppl (1993) 1.11

An analysis of the spectra of genetic activity produced by known or suspected human carcinogens. Mutat Res (1985) 1.10

Modulation of apoptosis by cigarette smoke and cancer chemopreventive agents in the respiratory tract of rats. Carcinogenesis (2001) 1.10

Dynamics of the human EEG during prolonged wakefulness: evidence for frequency-specific circadian and homeostatic influences. Neurosci Lett (1997) 1.09

Genetic activity profiles and pattern recognition in test battery selection. Mutat Res (1988) 1.08

Epidemiologic association between Gonorrhea and prostatic carcinoma. Urology (1975) 1.08

Invasive Haemophilus influenzae type f disease. Pediatr Infect Dis J (1995) 1.07

N-acetylcysteine inhibits endothelial cell invasion and angiogenesis. Lab Invest (1999) 1.06

[Concentration of poliomyelitis and influenza viruses studied with insoluble polyelectrolytes. Preliminary note]. G Ig Med Prev (1972) 1.06

Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity. Cancer Res (1985) 1.05

Evaluation of the genetic activity profiles of 65 pesticides. Mutat Res (1986) 1.05

Ductal spread in prostatic carcinoma. Cancer (1985) 1.05

The plaque-antiserum method: an assay of virus infectivity and an experimental model of virus infection. Appl Microbiol (1974) 1.04

"Headbanging" and carotid dissection. Br Med J (Clin Res Ed) (1983) 1.04

[Immunitary defense against polioviruses in various population samples in several years following Sabin vaccination]. Ann Sclavo (1972) 1.04

Differences in detection of DNA adducts in the 32P-postlabelling assay after either 1-butanol extraction or nuclease P1 treatment. Cancer Lett (1989) 1.02

The virological monitoring of water. I. Drinking water. Boll Ist Sieroter Milan (1974) 1.02

Metabolic deactivation of hexavalent chromium mutagenicity. Mutat Res (1978) 1.01

The virological monitoring of water. II. Sea water. Boll Ist Sieroter Milan (1974) 1.00

Nutrition and prostate cancer: a case-control study. Prostate (1985) 1.00

A survey of EPA/OPP and open literature on selected pesticide chemicals. II. Mutagenicity and carcinogenicity of selected chloroacetanilides and related compounds. Mutat Res (1999) 0.99

Cancer of the prostate and aging: an autopsy study in black men from Washington, DC, and selected African cities. Prostate (1982) 0.99

DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity. Cancer Res (1981) 0.98

The Genetic Activity Profile database. Environ Health Perspect (1991) 0.97

Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine. Int J Cancer (1995) 0.97

Relative efficacy of blastospores and aerial conidia of Paecilomyces fumosoroseus against the russian wheat aphid. J Invertebr Pathol (1998) 0.97

Activity profiles of developmental toxicity: design considerations and pilot implementation. Teratology (1991) 0.97

A review of the genetic and related effects of 1,3-butadiene in rodents and humans. Mutat Res (2000) 0.96

Blood hormone profiles in prostate cancer patients in high-risk and low-risk populations. Cancer (1981) 0.96

Chlorophyllin: a potent antimutagen against environmental and dietary complex mixtures. Mutat Res (1986) 0.95

Metabolic deactivation of mutagens in the Salmonella-microsome test. Nature (1978) 0.95

Specific-locus mutations induced in eukaryotes (especially mammalian cells) by radiation and chemicals: a perspective. Mutat Res (1989) 0.94

Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: results from a case--control multicenter study on lung cancer patients. Environ Health Perspect (1992) 0.94

Demonstration of ignition radiation temperatures in indirect-drive inertial confinement fusion hohlraums. Phys Rev Lett (2011) 0.93

Non-neonatal infection due to Listeria monocytogenes. Pediatr Infect Dis (1984) 0.92

Malignant tumors in American black and Nigerian children: a comparative study. J Natl Cancer Inst (1975) 0.92

Characterization of prostatic carcinoma among blacks: a preliminary report. Cancer Chemother Rep (1975) 0.92

Patterns of DNA adduct formation in liver and mammary epithelial cells of rats treated with 7,12-dimethylbenz(a)anthracene, and selective effects of chemopreventive agents. Cancer Res (1999) 0.92

Long-term home parenteral nutrition. Br J Hosp Med (1983) 0.91

Mutagenicity testing with TA97 and TA102 of 30 DNA-damaging compounds, negative with other Salmonella strains. Mutat Res (1985) 0.91

Age-related increases of 8-hydroxy-2'-deoxyguanosine and DNA-protein crosslinks in mouse organs. Mutat Res (1999) 0.91

Dose-related differences in DNA adduct levels in rodent tissues following skin application of complex mixtures from air pollution sources. Carcinogenesis (1990) 0.91

Kawasaki-like syndrome caused by carbamazepine. Pediatr Infect Dis J (1988) 0.90

Pycnodysostosis. A clinical, pathological, and ultramicroscopic study of a case. J Bone Joint Surg Am (1978) 0.90

Genetic activity profiles in the testing and evaluation of chemical mixtures. Teratog Carcinog Mutagen (1990) 0.90

Formation and persistence of nucleotide alterations in rats exposed whole-body to environmental cigarette smoke. Carcinogenesis (1999) 0.90

Metabolic activation of hepatocarcinogens in chronic hepatitis B. Mutat Res (1985) 0.89

Characterization of prostatic carcinoma among blacks: a continuation report. Cancer Treat Rep (1977) 0.89

DNA alterations in rat organs after chronic exposure to cigarette smoke and/or ethanol ingestion. FASEB J (1998) 0.88

Induction, persistence and modulation of cytogenetic alterations in cells of smoke-exposed mice. Carcinogenesis (1999) 0.88

Generalized glycogenosis and associated endocardial fibroelastosis. Report of 3 cases with biochemical studies. J Pediatr (1965) 0.88

Modulation of biomarkers by chemopreventive agents in smoke-exposed rats. Cancer Res (2001) 0.88

Genotoxic activity and potency of 135 compounds in the Ames reversion test and in a bacterial DNA-repair test. Mutat Res (1984) 0.87

Urban Jamaican children's exposure to community violence. West Indian Med J (2005) 0.87

Genetic activity profiles of anticancer drugs. Mutat Res (1996) 0.87

Inhibition by oral N-acetylcysteine of doxorubicin-induced clastogenicity and alopecia, and prevention of primary tumors and lung micrometastases in mice. Int J Oncol (1998) 0.87

Thermal inactivation of untreated and gamma-irradiated A2-Aichi-2-68 influenza virus. J Gen Virol (1973) 0.86

[On the use of a new technic for demonstration of plaques formed by poliomyelitis viruses]. G Ig Med Prev (1971) 0.86

Bilirubinuria: an early indicator of gallbladder hydrops associated with Kawasaki disease. J Pediatr Gastroenterol Nutr (1989) 0.86

DNA fragmentation, DNA-protein crosslinks, postlabeled nucleotidic modifications, and 8-hydroxy-2'-deoxyguanosine in the lung but not in the liver of rats receiving intratracheal instillations of chromium(VI). Chemoprevention by oral N-acetylcysteine. Mutat Res (1998) 0.86

Comparison of the effects of keto acid analogues and essential amino acids on nitrogen homeostasis in uremic patients on moderately protein-restricted diets. Am J Clin Nutr (1978) 0.86

[Thermal inactivation of hepatitis B surface antigen]. J Immunol (1978) 0.86

Benzo[a]pyrene diolepoxide-DNA adducts in alveolar macrophages of smokers. Carcinogenesis (1991) 0.86

Genetic toxicology data in the evaluation of potential human environmental carcinogens. Mutat Res (1999) 0.86

Formulation of Bacillus spp. for Biological Control of Plant Diseases. Phytopathology (2004) 0.85

Desquamative interstitial pneumonia. Report of a case of a recently described entity. Med Ann Dist Columbia (1966) 0.85

In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds. Carcinogenesis (1985) 0.85

Cancer biomarkers in human atherosclerotic lesions: no evidence of p53 involvement. Cancer Epidemiol Biomarkers Prev (1995) 0.85

Incidence of prostatic calcification in blacks in Washington, D.C., and selected African cities. Correlation of specimen roentgenographs and pathologic findings. Cooperative Prostatic Research Group. Urology (1979) 0.84

Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype. FASEB J (2001) 0.84

Metabolic reduction of chromium by alveolar macrophages and its relationships to cigarette smoke. J Clin Invest (1986) 0.84

Carcinogen metabolism and DNA adducts in human lung tissues as affected by tobacco smoking or metabolic phenotype: a case-control study on lung cancer patients. Mutat Res (1991) 0.84

Factors involved in the high incidence of prostatic cancer among American blacks. Prog Clin Biol Res (1981) 0.84

Protection by N-acetylcysteine of the histopathological and cytogenetical damage produced by exposure of rats to cigarette smoke. Cancer Lett (1992) 0.84